Free Trial
ASX:EYE

Nova Eye Medical (EYE) Stock Price, News & Analysis

Nova Eye Medical logo

About Nova Eye Medical Stock (ASX:EYE)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$34.22 million
P/E Ratio
N/A
Dividend Yield
1.23%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EYE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nova Eye Medical and its competitors with MarketBeat's FREE daily newsletter.

EYE Stock News Headlines

Nova Eye Medical Stock Price History
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Nova Eye Medical Discusses Future Expectations and Risks
Nova Eye Medical Sees Strong Sales Growth in Key Markets
See More Headlines

EYE Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Nova Eye Medical investors own include Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
ASX:EYE
CIK
N/A
Fax
N/A
Employees
14,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$8.79 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
A$23.32 million
Price / Cash Flow
N/A
Book Value
A$0.10 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
A$34.22 million
Optionable
Not Optionable
Beta
0.96
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:EYE) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners